Stephen R. Johnson

2 ta ish

Bristol-Myers Squibb (United States)

1. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

   Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng +3

   Maqola20025 iqtibos

   ABIABI:AkademIndex/2026.other.050870

2. The Trouble with QSAR (or How I Learned To Stop Worrying and Embrace Fallacy)

   Stephen R. Johnson

   Boshqa20075 iqtibos

   ABIABI:AkademIndex/2026.other.166497